Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein

Fig. 2

Mice immunization protocol. Group 1 received: Prime—pcDNA3.1(+)-HBZ (100 µg); Boost—MVA-HBZ 107 PFU and 2nd Boost—MVA-HBZ 107 PFU. Group 2 received: Prime—Saline; Boost—MVA (wt) 107 PFU and 2nd Boost—MVA (wt) 107 PFU. Group 3 received: Prime—Addavax 1:1; Boost—Saline and 2nd Boost—Saline. N = 7. Immunizations were performed at 14 days-intervals

Back to article page

Virology Journal

ISSN: 1743-422X